Craneware (LON:CRW) Stock Price Passes Above 200 Day Moving Average - Here's Why

Key Points

• Craneware plc's stock price has surpassed its 200-day moving average, signaling a potential change in trading sentiment as it reached GBX 2,185 ($29.36) during trading.
• Analysts maintain a positive outlook, with several firms issuing "buy" ratings and target prices ranging from GBX 2,650 to GBX 2,800, resulting in a consensus target price of GBX 2,725.
• The company's current financial ratios include a debt-to-equity ratio of 12.22 and a market capitalization of approximately £754.98 million, indicating a potentially high leverage situation.

Craneware plc (LON:CRW - Get Free Report)'s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 2,005.17 ($27.13) and traded as high as GBX 2,185 ($29.56). Craneware shares last traded at GBX 2,140 ($28.95), with a volume of 27,448 shares.

Analysts Set New Price Targets

A number of research firms have recently commented on CRW. Shore Capital reiterated a "buy" rating and issued a GBX 2,650 price objective on shares of Craneware in a research note on Wednesday, July 16th. Berenberg Bank began coverage on Craneware in a research note on Wednesday, July 16th. They issued a "buy" rating and a GBX 2,800 price objective on the stock. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of GBX 2,725.

Craneware Stock Up 7.7%

The company has a debt-to-equity ratio of 12.22, a current ratio of 0.63 and a quick ratio of 1.00. The stock has a market capitalization of £819.74 million, a P/E ratio of 5,447.06 and a beta of 0.28. The firm has a 50 day moving average of GBX 2,268.01 and a 200-day moving average of GBX 2,007.73.

Craneware Company Profile

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.